Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

BioAtla is extending its runway beyond key clinical readouts in 1H 2026 by restructuring and realigning resources, which includes a workforce reduction of over 30%. The Company estimates that it will ...

Corvus is collaborating with the Kidney Cancer Research Consortium (KCRC) in a Phase 1b/2 clinical trial evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC ...

Overexpression of ROR2, a noncanonical wnt5A signaling receptor ... About Evalstotug Evalstotug, is a CAB anti-CTLA-4 antibody that is being developed as an immuno-oncology agent with the goal ...

These technologies have revealed immune evasion strategies by tumors, leading to breakthroughs in cancer immunotherapies targeting checkpoints such as PD-1 and CTLA-4. Similarly ... pathways such as ...

TNF-α mediates distinct signaling pathways through two structurally distinct ... TNFR2 targeting may be combined with well-established immune checkpoint targets, including CTLA-4 and Tim3, in order to ...

The stock market has reacted quickly to policy uncertainty and tariffs, impacting Nasdaq stocks. Technical analyst Helene Meisler sees a bearish, oversold market, hinting at potential rally ...

CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

Astrologer Lisa Stardust shares what each zodiac sign can expect during the 4/4 portal on April 4 April 4 is the day the 4/4 portal will open up to us. The 4/4 portal is known to augment our lives ...